Hormone Replacement Therapy Market

Mar 2021| MRS114A| Market Research Studies

Report Highlights

The scope of this report covers the different types of Hormone Replacement Therapy, impact of COVID-19 on the market, and therapies used to treat the disorder. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each type, route of administration, disease and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional Hormone Replacement Therapy markets; it explains the major market drivers of the Global Hormone Replacement Therapy industry, current trends within the industry, major applications and the regional dynamics of the Global Hormone Replacement Therapy Market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the Global Hormone Replacement Therapy Market.

Report Includes

  • 39 tables and 47 figures
  • An up-to-date analysis of the Global Hormone Replacement Therapy Market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for Global Hormone Replacement Therapy Market, and corresponding market share analysis by type, route of administration, disease, and region.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Hormone Replacement Therapy, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of promising new therapies, and products still in the development and testing stages, and their probability of successful commercial launch within the next five years
  • Impact of COVID-19 on the Hormone Replacement Therapy Market as compared to overall global economy.
  • Insight into the growth development strategies of major Hormone Replacement Therapy manufacturers and their key competitive landscape
  • Descriptive company profiles of the leading market participants, including Abbott Laboratories, Bayer AG, Eli Lilly & Company, F. Hoffmann-La Roche AG, Hisamitsu Pharmaceutical Co., Inc., and others.

Summary

Hormone Replacement Therapy commonly known as menopausal hormone therapy is a treatment given to the patients having low levels of growth hormones in their body. The therapy aids in replenishing the growth hormones levels by balancing the levels of estrogen and progesterone in females during the menopause. During this imbalance, the females face symptoms such as, night sweats, genito-urinary problems, hot flushes, and many others. Increasing adoption rates of hormone replacement therapy among women is one of the key drivers for the market. Apart from that, rise in the number of product approvals would further bolster the market growth.

According to the studies, about 80% of the female suffers hormonal imbalance. Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, and Testosterone Hormone Replacement Therapy are namely four therapies which are used to treat Hormone Replacement Therapy.

The Global Hormone Replacement Therapy Market was valued at $18.24 billion in 2020 and is expected to witness a steady growth at a CAGR of 7.46%.

  • Table 1 : Global Hormone Replacement Therapy Market, Through 2026
  • Table 2 : Global Hormone Replacement Therapy Market, by Type, Through 2026
  • Table 3 : Global Hormone Replacement Therapy Market, by Route of Administration, Through 2026
  • Table 4 : Global Hormone Replacement Therapy Market, by Disease, Through 2026
  • Table 5 : Global Hormone Replacement Therapy Market, by Region, Through 2026
  • Table 6 : North America Hormone Replacement Therapy Market, by Type, Through 2026
  • Table 7 : North America Hormone Replacement Therapy Market, by Route of Administration, Through 2026
  • Table 8 : North America Hormone Replacement Therapy Market, by Disease, Through 2026
  • Table 9 : North America Hormone Replacement Therapy Market, by Country, Through 2026
  • Table 10 : Europe Hormone Replacement Therapy Market, by Type, Through 2026
  • Table 11 : Europe Hormone Replacement Therapy Market, by Route of Administration, Through 2026
  • Table 12 : Europe Hormone Replacement Therapy Market, by Disease, Through 2026
  • Table 13 : Europe Hormone Replacement Therapy Market, by Country, Through 2026
  • Table 14 : Asia-Pacific Hormone Replacement Therapy Market, by Type, Through 2026
  • Table 15 : Asia-Pacific Hormone Replacement Therapy Market, by Route of Administration, Through 2026
  • Table 16 : Asia-Pacific Hormone Replacement Therapy Market, by Disease, Through 2026
  • Table 17 : Asia-Pacific Hormone Replacement Therapy Market, by Country, Through 2026
  • Table 18 : South America Hormone Replacement Therapy Market, by Type, Through 2026
  • Table 19 : South America Hormone Replacement Therapy Market, by Route of Administration, Through 2026
  • Table 20 : South America Hormone Replacement Therapy Market, by Disease, Through 2026
  • Table 21 : South America Hormone Replacement Therapy Market, by Country, Through 2026
  • Table 22 : Middle East & Africa Hormone Replacement Therapy Market, by Type, Through 2026
  • Table 23 : Middle East & Africa Hormone Replacement Therapy Market, by Route of Administration, Through 2026
  • Table 24 : Middle East & Africa Hormone Replacement Therapy Market, by Disease, Through 2026
  • Table 25 : Middle East & Africa Hormone Replacement Therapy Market, by Country, Through 2026
  • Table 26 : Abbott Laboratories: Financial Performance, Through 2020
  • Table 27 : Bayer AG: Financial Performance, Through 2020
  • Table 28 : Eli Lilly & Company: Financial Performance, Through 2020
  • Table 29 : F. Hoffmann-La Roche AG: Financial Performance, Through 2020
  • Table 30 : Hisamitsu Pharmaceutical Co., Inc.: Financial Performance, Through 2020
  • Table 31 : Merck & Co., Inc.: Financial Performance, Through 2020
  • Table 32 : Mylan N.V.: Financial Performance, Through 2020
  • Table 33 : Novartis AG: Financial Performance, Through 2020
  • Table 34 : Novo Nordisk A/S: Financial Performance, Through 2020
  • Table 35 : Pfizer Inc.: Financial Performance, Through 2020
  • Table 36 : Allergan Plc: Financial Performance, Through 2020
  • Table 37 : Endo International plc: Financial Performance, Through 2020
  • Table 38 : Ferring Pharmaceuticals S.A.: Financial Performance, Through 2020
  • Table 39 : Clarus Therapeutics, Inc.: Financial Performance, Through 2020
  • Figure 1 : Global Hormone Replacement Therapy Market
  • Figure 2 : Global Hormone Replacement Therapy Market, by Value, 2019-2026
  • Figure 3 : Global Hormone Replacement Therapy Market, by Value, by Type, 2019-2026
  • Figure 4 : Global Hormone Replacement Therapy Market, by Value, by Route of Administration, 2019-2026
  • Figure 5 : Global Hormone Replacement Therapy Market, by Value, by Disease, 2019-2026
  • Figure 6 : Global Hormone Replacement Therapy Market, by Value, by Region, 2020
  • Figure 7 : Global Hormone Replacement Therapy Market, by Value, by Company, 2020
  • Figure 8 : Global Hormone Replacement Therapy Market, Product Map, 2020
  • Figure 9 : North America Hormone Replacement Therapy Market, by Value, 2019-2026
  • Figure 10 : North America Hormone Replacement Therapy Market, by Value, by Type, 2019-2026
  • Figure 11 : North America Hormone Replacement Therapy Market, by Value, by Route of Administration, 2019-2026
  • Figure 12 : North America Hormone Replacement Therapy Market, by Value, by Disease, 2019-2026
  • Figure 13 : North America Hormone Replacement Therapy Market, by Value, by Country, 2020
  • Figure 14 : Europe Hormone Replacement Therapy Market, by Value, 2019-2026
  • Figure 15 : Europe Hormone Replacement Therapy Market, by Value, by Type, 2019-2026
  • Figure 16 : Europe Hormone Replacement Therapy Market, by Value, by Route of Administration, 2019-2026
  • Figure 17 : Europe Hormone Replacement Therapy Market, by Value, by Disease, 2019-2026
  • Figure 18 : Europe Hormone Replacement Therapy Market, by Value, by Country, 2020
  • Figure 19 : Asia-Pacific Hormone Replacement Therapy Market, by Value, 2019-2026
  • Figure 20 : Asia-Pacific Hormone Replacement Therapy Market, by Value, by Type, 2019-2026
  • Figure 21 : Asia-Pacific Hormone Replacement Therapy Market, by Value, by Route of Administration, 2019-2026
  • Figure 22 : Asia-Pacific Hormone Replacement Therapy Market, by Value, by Disease, 2019-2026
  • Figure 23 : Asia-Pacific Hormone Replacement Therapy Market, by Value, by Country, 2020
  • Figure 24 : South America Hormone Replacement Therapy Market, by Value, 2019-2026
  • Figure 25 : South America Hormone Replacement Therapy Market, by Value, by Type, 2019-2026
  • Figure 26 : South America Hormone Replacement Therapy Market, by Value, by Route of Administration, 2019-2026
  • Figure 27 : South America Hormone Replacement Therapy Market, by Value, by Disease, 2019-2026
  • Figure 28 : South America Hormone Replacement Therapy Market, by Value, by Country, 2020
  • Figure 29 : Middle East & Africa Hormone Replacement Therapy Market, by Value, 2019-2026
  • Figure 30 : Middle East & Africa Hormone Replacement Therapy Market, by Value, by Type, 2019-2026
  • Figure 31 : Middle East & Africa Hormone Replacement Therapy Market, by Value, by Route of Administration, 2019-2026
  • Figure 32 : Middle East & Africa Hormone Replacement Therapy Market, by Value, by Disease, 2019-2026
  • Figure 33 : Middle East & Africa Hormone Replacement Therapy Market, by Value, by Country, 2020
  • Figure 34 : Abbott Laboratories: Revenue Share, 2020
  • Figure 35 : Bayer AG: Revenue Share, 2020
  • Figure 36 : Eli Lilly & Company: Revenue Share, 2020
  • Figure 37 : F. Hoffmann-La Roche AG: Revenue Share, 2020
  • Figure 38 : Hisamitsu Pharmaceutical Co., Inc.: Revenue Share, 2020
  • Figure 39 : Merck & Co., Inc.: Revenue Share, 2020
  • Figure 40 : Mylan N.V.: Revenue Share, 2020
  • Figure 41 : Novartis AG: Revenue Share, 2020
  • Figure 42 : Novo Nordisk A/S: Revenue Share, 2020
  • Figure 43 : Pfizer Inc.: Revenue Share, 2020
  • Figure 44 : Allergan Plc: Revenue Share, 2020
  • Figure 45 : Endo International plc: Revenue Share, 2020
  • Figure 46 : Ferring Pharmaceuticals S.A.: Revenue Share, 2020
  • Figure 47 : Clarus Therapeutics, Inc.: Revenue Share, 2020

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report